Drug–drug interactions (DDI) occurring with potentially inappropriate medications (PIM) are
additional risk factors that may increase the inappropriate character of PIM. The aim of this …

Introduction Optimizing medication use is a major issue in older patients with cancer and
pharmacists are increasingly involved in their multidisciplinary care. The implementation of …

Purpose Polypharmacy is prevalent in older adults starting cancer treatment and associated
with potentially inappropriate medications (PIM), potential drug-drug interactions (DDI), and …

Background: Polypharmacy and potentially inappropriate medications (PIMs) are common
among older adults with blood cancers, but their association with frailty and how to manage …

Background Both polypharmacy and potentially inappropriate medication (PIM) intake are
highly prevailing in older cancer patients. However, only studies on the association of …

Malnutrition is common in cancer patients and can occur throughout a patient's disease
course. The contributors to the clinical syndrome of cancer cachexia are often multifactorial …

Background Patients receiving palliative care often have existing comorbidities
necessitating the prescribing of multiple medications. To maximize quality of life in this …

Background Polypharmacy in older adults with cancer receiving chemotherapy leads to
increased risks of drug interactions, translating in potential hazardous health outcomes. This …

Purpose Polypharmacy is a common problem among older adults. However, its prevalence
and impact on the clinical outcomes of anticancer treatment, such as survival and adverse …

Purpose Palliative cancer patients can benefit from deprescribing of potentially
inappropriate medications (PIMs). Tools and guidelines developed for the geriatric …